Evidence map›Paper›PMID 41760338›Full record

ArticleIn vivo (Athens, Greece)

Markus Maulhardt, Alexander C Angleitner, Rehsan Akdas, Wilken Harms, Patricia Scharfenberg, Judith Büntzel

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Markus MaulhardtDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany markus.maulhardt@med.uni-goettingen.de.
Alexander C AngleitnerDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.
Rehsan AkdasDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.
Wilken HarmsDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.
Patricia ScharfenbergDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.
Judith BüntzelDepartment of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany judith.buentzel@med.uni-goettingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimGeotrichosis caused by PATIENTS AND

methodsA systematic online search was conducted, and suitable case reports were retrieved for subsequent retrospective analysis. We eventually selected data on 22 cases for final analysis according to the PRISMA guidelines. To summarize the demographic and clinical variables, descriptive statistical measures were applied. Besides, we contributed one additional case of a leukemia patient with catastrophic

results

conclusionAlthough deemed a yeast of low virulence,

Indexed as

GeotrichosisNeoplasmsOpportunistic InfectionsAdultAgedAged, 80 and overAntifungal AgentsChildChild, PreschoolFatal OutcomeFemaleGeotrichumHumansImmunocompromised HostInvasive Fungal InfectionsLeukemia, Myeloid, AcuteAntifungal AgentsgeotrichosisGeotrichum candidumimmunosuppressioninfectionmycosis

Identifiers

PMID41760338
PMCPMC12949917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.